• Tidak ada hasil yang ditemukan

Supplement

N/A
N/A
Protected

Academic year: 2023

Membagikan "Supplement"

Copied!
3
0
0

Teks penuh

(1)

Supplemental Digital Content

Supplemental Table 1: Similar as Table 3, but with specific agreements on the different components of the PELOD-2. Categories represents the number of points that are possible for each organ.

Study

Overall agreement

[%]

Specific agreement per point categories

[%]

Patients number Cohen’s kappa (95% CI) 1st 2nd 3rd 4th 1st 2nd 3rd 4th

Glasgow Coma Score

2 96 98 95 73 276 44 22 0.84 (0.72-0.95)

3 77 87 14 0 274 28 12 0.06 (-0.02-0.14)

2+3 87 92 64 47 550 72 34 0.52 (0.39-0.64)

Pupillary reaction

2 100 100 342 – a

3 100 100 314 – a

2+3 100 100 656 – a

Lactate

2 98 99 88 100 308 32 2 0.88 (0.76-1)

3 96 98 86 89 263 42 9 0.88 (0.79-0.98)

2+3 97 98 86 91 571 74 11 0.88 (0.81-0.95)

Mean arterial pressure

2 84 91 87 77 42 97 156 70 19 0.77 (0.69-0.85)

3 73 82 77 69 33 83 140 61 30 0.59 (0.49-0.7)

2+3 78 87 82 73 37 180 296 131 49 0.68 (0.62-0.75)

Creatinine

2 88 90 86 198 144 0.76 (0.67-0.86)

3 94 93 95 131 183 0.88 (0.81-0.96)

2+3 91 91 91 329 327 0.82 (0.76-0.88)

Invasive ventilation

2 94 95 91 223 119 0.86 (0.78-0.94)

3 93 82 96 61 253 0.78 (0.65-0.9)

2+3 93 92 94 284 372 0.86 (0.81-0.92)

PaO2 : FiO2

2 99 100 0 341 1 0 b

3 90 95 0 299 15 -0.02 (-0.05-0.01)

2+3 95 98 0 640 16 -0.02 (-0.03-0)

PCO2

2 92 95 75 100 285 53 4 0.75 (0.61-0.88)

3 87 91 75 0 230 83 1 0.67 (0.55-0.79)

2+3 90 94 75 80 515 136 5 0.71 (0.62-0.8)

Leukocytes

2 99 99 50 338 4 0.5 (-0.11-1.1)

3 97 98 55 303 11 0.53 (0.17-0.89)

2+3 98 99 53 641 15 0.52 (0.22-0.83)

Platelets

2 92 97 80 0 0 289 45 5 3 0.75 (0.64-0.86)

3 74 78 75 50 164 114 36 0.53 (0.42-0.65)

2+3 84 90 77 44 0 453 159 41 3 0.64 (0.56-0.72)

a Complete agreement with a null variance

b Null variance in one group

(2)

Supplemental Fig. 1: Plotted confusion matrix of the aPELOD-2 and mPELOD-2

2 5 4 0 0

2 5 2 3 0

1 7 1 8

1 5 0 2

2 7 1 4 9

3 1 7 0

7 4

3 2 8

0 0

0

1 3 1 1 2

1 0 1 7 5

2 0 4 0 0 0

3 1 6 1 0 0

1 4 6 9 3

0 0 0 0

2 8 1 0 0

9 3 2 0

0 1 5

3 1 2 1 3

3 0

7 8 0 0 0

1 6 1 2 2 0 0

3 2 1 4 8 0

5 1 5 1 1 9

2 4 1 2 0

3 1 5 1 0

0 1 2

L e u k o c y t e s P la t e le t s

C r e a t i n in e I n v a s i v e v e n t il a t i o n P a O 2 - F i O 2 r a t io P C O 2

G C S P u p il la r y r e a c t io n L a c t a t e m ia Mean arterial pressure

0 2 0 1 2 3

0 2 0 3 0 2 0 1 3

0 1 4 0 5 0 1 4 0 2 3 6

0 2 3 6

0 1 3 0

1 4

0 2 0

5

0 3

0 1 2 3 0

1 4

0 2

0 2

m P E L O D - 2

aPELOD-2

0 1 0 0 2 0 0 3 0 0 F r e q u e n c i e s a P E L O D - 2 v s m P E L O D - 2 c o n f u s i o n m a t r i x

(3)

Supplemental Table 2: Missing, normal and abnormal values for aPELOD-2 and mPELOD-2 (study 3)

Missing Values Normal Values Abnormal Values aPELOD2 mPELOD2 aPELOD2 mPELOD2 aPELOD2 mPELOD2 Glasgow Coma Score 29 (18.5%) 129 (82.2%) 62 (39.5%) 0 (0%) 66 (42%) 28 (17.8%) Pupillary reaction 47 (29.9%) 75 (47.8%) 109 (69.4%) 0 (0%) 1 (0.6%) 82 (52.2%) Lactate 4 (2.5%) 22 (14%) 117 (74.5%) 0 (0%) 36 (22.9%) 135 (86%) Mean arterial pressure 0 (0%) 5 (3.2%) 11 (7%) 0 (0%) 146 (93%) 152 (96.8%) Creatinine 0 (0%) 6 (3.8%) 56 (35.7%) 0 (0%) 101 (64.3%) 151 (96.2%) Invasive ventilation 16 (10.2%) 0 (0%) 6 (3.8%) 35 (22.3%) 135 (86%) 122 (77.7%) PaO2 : FiO2 22 (14%) 13 (8.3%) 133 (84.7%) 0 (0%) 2 (1.3%) 144 (91.7%) PCO2 0 (0%) 0 (0%) 96 (61.1%) 10 (6.4%) 61 (38.9%) 147 (93.6%) Leukocytes 2 (1.3%) 8 (5.1%) 146 (93%) 0 (0%) 9 (5.7%) 149 (94.9%) Platelets 2 (1.3%) 8 (5.1%) 56 (35.7%) 0 (0%) 99 (63.1%) 149 (94.9%)

Referensi

Dokumen terkait

9- Giảm chi phí : Yêu cầu đặt ra cho hệ thống LTE là giảm thiểu được chi phí trong khi vẫn duy trì được hiệu suất nhằm đáp ứng được cho tất cả các dịch vụ.Các vấn đề đường truyền,hoạt

iainkudus.ac.id PERSETUJUAN PEMBIMBING SKRIPSI Yang bertanda tangan dibawah ini menyatakan bahwa skripsi saudara: Nama : Isrina Nur Maulida NIM : 1720210111 Fakultas : Ekonomi